How Different Levels of CPAP Deliver Oxygen to Preterm Babies
Official title: Oxygen Delivery in CPAP and Its Relationship With Regional Lung Ventilation in Preterm Infants
Run by University of Arkansas · NCT07674953 · Data updated 2026-11-12
This study tests how much oxygen actually reaches preterm infants when they receive nasal CPAP at different air pressures.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | University of Arkansas Academic / other |
| Locations | 2 sites (Little Rock, Arkansas and 1 other locations) |
| Status | Recruiting |
| Started | April 15, 2026 |
| Main results expected | December 2026 |
| Study ends | June 2027 |
| Registry record updated | June 30, 2026 |
| Trial ID | NCT07674953 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Preterm infants (<35 weeks gestation) who are stable on nasal CPAP and using 22-40% supplemental oxygen.
✕Probably not a fit
Infants requiring invasive ventilation, with oxygen needs >40%, or with major congenital heart or lung anomalies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study aims to measure the true oxygen delivery to preterm infants on nasal CPAP and how it may vary with different airway pressures. Researchers will collect measurements that are difficult to obtain in typical clinical care to see if the doctor-ordered oxygen matches what reaches the baby’s airway. The study focuses on infants born before 35 weeks who are stable on CPAP and using 22-40% supplemental oxygen, excluding those with higher oxygen needs or invasive ventilation. Findings could clarify whether adjustments in CPAP pressure change actual oxygen delivery and lung expansion. The study is conducted at the University of Arkansas for Medical Sciences in Little Rock, led by that institution.
Why it matters
Potential benefit: If successful, the study could help clinicians optimize oxygen delivery and CPAP settings for safer, more effective respiratory support.
How similar studies have gone: Previous work has explored CPAP effects on oxygen delivery, but direct measurements in this setting are limited, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Gestational age at birth must be less than 35 weeks of completed gestation as documented in the subject's initial history and physical * The infant must be stable while receiving nasal CPAP at any pressure level at the time of study * The infant must be receiving 22-40% at the time of the study Exclusion Criteria: * Oxygen requirements greater than 40% at time of enrollment * currently receiving invasive ventilation or not requiring ventilatory support * Major congenital anomalies of the heart and/or lungs
Where it's running
-
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States Recruiting -
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States Not yet recruiting
Study contacts
- Study coordinator: Nicholas A Rowley, MD
- Email: NARowley@uams.edu
- Phone: 940-230-5002
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Surfactant delivery methods in preterm infants with RDS in Sweden
This study tests different ways of giving surfactant to preterm babies with respiratory distress to see which method works best when care is routine.
-
Video-guided vs direct laryngoscopy for less invasive surfactant delivery in extremely preterm infants
This trial tests whether using video laryngoscopy helps give surfactant on the first try more often than direct laryngoscopy in extremely preterm babies needing surfactant.
-
Lung volume changes with synchronized noninvasive ventilator support in preterm infants
This study will use a noninvasive imaging belt to see if synchronized ventilator inflations produce larger lung volumes than unsynchronized or backup inflations in very preterm infants on sNIPPV.
-
Lung ultrasound to predict breathing problems in late‑preterm babies
We will test whether early point‑of‑care lung ultrasound can predict which late‑preterm newborns will have breathing problems in the first 48 hours of life.
-
Comparing two ways to wean preterm babies from high-frequency oscillatory ventilation
This trial tests two different methods to stop high-frequency oscillatory ventilation in preterm infants with respiratory distress syndrome to see which leads to fewer complications.
-
SalSA vs LISA: Surfactant Delivery in Preterm Infants
This study tests whether giving surfactant through SALSA (a supraglottic airway) is safer and more effective than the LISA thin-catheter method in babies born at 29-36 weeks who need help breathing.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.